NCT05728125View on ClinicalTrials.gov

Pinpointing the Factors Affecting Clinical Trial Experiences of Glioblastoma Patients

Not yet recruitingOBSERVATIONAL
Enrollment

500

Participants

Timeline

Start Date

March 31, 2024

Primary Completion Date

March 31, 2025

Study Completion Date

March 31, 2026

Conditions
Glioblastoma
Sponsors
All Listed Sponsors
lead

Power Life Sciences Inc.

INDUSTRY

NCT05728125 - Pinpointing the Factors Affecting Clinical Trial Experiences of Glioblastoma Patients | Biotech Hunter | Biotech Hunter